Clinical Trial Update: Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the pharmacokinetics and safety of neratinib in healthy subjects and in individuals with chronic liver disease to assess the impact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency
• Liver Disease

Drugs mentioned

• Neratinib (Nerlynx) (neratinib)

Snippet

Sponsor: Puma Biotechnology, Inc. | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED